Ergocalciferol and Dyazide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ergocalciferol (ergocalciferol) and Dyazide (hydrochlorothiazide; triamterene). Common drug interactions include memory impairment among females and oedema peripheral among males.
The phase IV clinical study analyzes what interactions people have when they take Ergocalciferol and Dyazide. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.
What is Ergocalciferol?
Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.
What is Dyazide?
Dyazide has active ingredients of hydrochlorothiazide; triamterene. It is often used in high blood pressure. eHealthMe is studying from 11,506 Dyazide users. Check the latest studies of Dyazide.
46 people who take Ergocalciferol and Dyazide together, and have interactions are studied.

What are the common drug interactions of Ergocalciferol and Dyazide, by gender? *:
female:
- Memory impairment
- Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Muscular weakness (muscle weakness)
- Nausea (feeling of having an urge to vomit)
- Oral pain
- Pain in extremity
- Photophobia (extreme sensitivity to light)
- Rash
- Rhinorrhoea (watery mucus discharge from the nose)
- Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
male:
- Oedema peripheral (superficial swelling)
- Pain in extremity
- Stress fracture (fracture of a bone caused by repeated (rather than sudden) mechanical stress)
- Tibia fracture (fracture of lower leg bone)
- Anxiety
- Depression
- Aggression
- Bipolar disorder (mood disorder)
- Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)
- Hallucination (an experience involving the perception of something not present)
What are the common drug interactions of Ergocalciferol and Dyazide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Jaw disorder (jaw disease)
- Local swelling (swelling at the site of some application of substance or injury)
- Neck pain
- Osteolysis (dissolution of bone)
- Osteomyelitis (infection of bone)
- Osteonecrosis of jaw (death of bone of jaw)
- Pain in jaw
- Subcutaneous abscess
- Urinary retention (the inability to completely or partially empty the bladder)
- Vitamin d decreased
60+:
- Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Neck pain
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Visual impairment
- Kidney infection
- Abdominal discomfort
- Anaphylactic reaction (serious allergic reaction)
- Appetite disorder (abnormal eating habits)
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 15.22%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 13.04%
- Multiple Myeloma (cancer of the plasma cells): 5 people, 10.87%
- High Blood Cholesterol: 5 people, 10.87%
- Stress And Anxiety: 4 people, 8.70%
- Pain: 4 people, 8.70%
- Neuralgia (pain in one or more nerves): 4 people, 8.70%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 8.70%
- Gait Disturbance: 4 people, 8.70%
- Renal Disorder (kidney disease): 3 people, 6.52%
* Approximation only. Some reports may have incomplete information.
Do you take Ergocalciferol and Dyazide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ergocalciferol (32,652 reports)
- Dyazide (11,506 reports)
Browse all drug interactions of Ergocalciferol and Dyazide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ergocalciferol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Dyazide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ergocalciferol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dyazide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on ergocalciferol and hydrochlorothiazide; triamterene (the active ingredients of Ergocalciferol and Dyazide, respectively), and Ergocalciferol and Dyazide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Emend cause Clonus? - now
- Drug interactions of Zyrtec and Caplyta - 5 seconds ago
- Haemolytic Uraemic Syndrome and Blood Alkaline Phosphatase Increased - 16 seconds ago
- Could Turmeric cause Smell - Impaired? - 18 seconds ago
- Could Metformin cause Diabetic Gastroparesis? - 21 seconds ago
- Could Amoxicillin And Clavulanate Potassium cause Dry Mouth? - 21 seconds ago
- Could Glucotrol cause Joint Injury? - 22 seconds ago
- Could Cozaar cause Cardiac Arrest? - 22 seconds ago
- Generalized Anxiety Disorder and Cough - 26 seconds ago
- Could Gilenya cause Eye Movement Disorder? - 28 seconds ago